Investing Profile

Ralph (Chris) Christoffersen

InvestorVC
Special Partner at Lightstone Ventures
morgenthaler.comBoulder, Colorado
Photo of Ralph (Chris) Christoffersen, Lightstone Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Barron Park Association Network
96 CONNECTIONS
Barron Park Association Network
96 CONNECTIONS
Barron Park Association Network
96 CONNECTIONS
Barron Park Association Network
96 CONNECTIONS
Barron Park Association Network
96 CONNECTIONS
cb
$100K - $5.0M
$1.5M
18
$250M
CompanyStageDateRound SizeTotal Raised
Elcelyx Therapeutics
Series EOct 2015$40M
Series CFeb 2014$25M
Series BAug 2012$4M
$69M
Calithera Biosciences
Series DOct 2013$35M
Series CDec 2012$2M
Series UnknownNov 2011$4M
Series AJul 2010$40M
$81M
Co-investors: Larry Lasky (The Column Group), Jean George (Advanced Technology Ventures), Christoph Westphal (Self-employed)
Scioderm
Series AApr 2013$16M
$16M
Gyre Therapeutics
Post Ipo EquityApr 2013$5M
Post Ipo EquitySep 2012$13M
Post Ipo EquityDec 2008$40M
Series BFeb 2006$30M
$88M
Co-investors: Asish Xavier (Johnson & Johnson Innovation), Nassim Usman (Ribozyme Pharmaceuticals)
Stemgent
Series BJun 2011$11M
Debt FinancingNov 2009$3M
Series BMar 2009$14M
Series AJul 2008$7M
$35M
Adastra Pharmaceuticals
Series UnknownApr 2010$5M
Series AMar 2007$40M
$45M
Professor of Chemistry Barron Park AssociationPresent
Vice Chancellor for Academic Affairs Barron Park AssociationPresent
Director Biotecnology Upjohn Pharmaceuticals LtdPresent
Executive Director Biotechnology Upjohn Pharmaceuticals LtdPresent
Vice President Biotechnology & Basic Research Support Upjohn Pharmaceuticals LtdPresent
Vice President US Research Barron Park AssociationPresent
Senior Vice President and Director, US Research Barron Park AssociationPresent
President Barron Park AssociationPresent
Professor of Chemistry The University of KansasPresent
Vice Chancellor for Academic Affairs The University of KansasPresent
President Colorado State UniversityPresent
WW Vice President Discovery Research Upjohn Pharmaceuticals LtdPresent
CEO and Chairman of the Board Ribozyme PharmaceuticalsPresent
Partner & Life Science Team Leader MorgenthalerPresent
Founding Partner Lightstone VenturesPresent
Special Partner Lightstone VenturesPresent
Indiana University Bloomington Ph.D. Physical Chemistry
Cornell College BS Chemistry & Mathematics; Minor in Physics
Indiana University Bloomington Ph.D. Physical Chemistry
Sign in with Google →
Sign in with Google →